检索结果 - Andrea Ruzza
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia 由 Michael J. Koren, Marc S. Sabatine, Robert P. Giugliano, Gisle Langslet, Stephen D. Wiviott, Helina Kassahun, Andrea Ruzza, Yuhui Ma, Ransi Somaratne, Frederick J. Raal
出版 2017Artigo -
5
-
6
-
7
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies 由 Frederick J. Raal, Robert A. Hegele, Andrea Ruzza, J. Antonio G. López, Ajay Bhatia, Johnny Wu, Huei Wang, Daniel Gaudet, Albert Wiegman, Jian Wang, Raúl D. Santos
出版 2024Artigo -
8
-
9
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia 由 Albert Wiegman, Andrea Ruzza, G. Kees Hovingh, Raul D. Santos, François Mach, Claudia Stefanutti, Ilse K. Luirink, Ian Bridges, Bei Wang, Ajay Bhatia, Frederick J. Raal, John J.P. Kastelein, Daniel Gaudet
出版 2024Artigo -
10
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia 由 Albert Wiegman, Andrea Ruzza, G.K. Hovingh, Raúl D. Santos, François Mach, C. Stefanutti, Ilse K. Luirink, Ian Bridges, B Wang, A.K. Bhatia, Frederick J. Raal, John J.P. Kastelein, D. Gaudet
出版 2022Artigo -
11
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia 由 Daniel Gaudet, Andrea Ruzza, Ian Bridges, Paul Maruff, Adrian Schembri, Andrew Hamer, François Mach, Jean Bergeron, Isabelle Gaudet, Julie St‐Pierre, John J.P. Kastelein, G. Kees Hovingh, Albert Wiegman, Frederick J. Raal, Raúl D. Santos
出版 2022Artigo -
12
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment 由 Raúl D. Santos, Andrea Ruzza, Bei Wang, Paul Maruff, Adrian Schembri, Ajay Bhatia, François Mach, Jean Bergeron, Isabelle Gaudet, Julie St‐Pierre, John J.P. Kastelein, G. Kees Hovingh, Albert Wiegman, Daniel Gaudet, Frederick J. Raal
出版 2023Artigo -
13
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia 由 Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh, Albert Wiegman, François Mach, Christopher E. Kurtz, Andrew Hamer, Ian Bridges, Andrea Bartuli, Jean Bergeron, T Szamosi, Saikat Santra, Claudia Stefanutti, Olivier Descamps, Susanne Greber‐Platzer, Ilse K. Luirink, John J.P. Kastelein, Daniel Gaudet
出版 2020Artigo
相关主题
Medicine
Internal medicine
Apolipoprotein A1
Cholesterol
Evolocumab
Lipoprotein
LDL receptor
PCSK9
Familial hypercholesterolemia
Randomized controlled trial
Adverse effect
Alirocumab
Alternative medicine
Pathology
Placebo
Apolipoprotein B
Cardiology
Pediatrics
Randomization
Allele
Biology
Carotid arteries
Clinical endpoint
Clinical trial
Environmental health
Gastroenterology
Gene
Genetics
Heterozygote advantage
Intima-media thickness